PMC:7228307 / 39882-40048 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7228307","sourcedb":"PMC","sourceid":"7228307","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7228307","text":"Thus, the choice of IgG subclass for therapeutic mAb engineering is an important first step for engineering of novel mAbs of improved specificity, potency and safety.","tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T349","span":{"begin":20,"end":23},"obj":"Body_part"}],"attributes":[{"id":"A349","pred":"fma_id","subj":"T349","obj":"http://purl.org/sig/ont/fma/fma62872"},{"subj":"T349","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-sample-sentences","denotations":[{"id":"T224","span":{"begin":0,"end":166},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T224","pred":"source","obj":"LitCovid-sample-sentences"}]},{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T348","span":{"begin":20,"end":23},"obj":"Body_part"}],"attributes":[{"id":"A348","pred":"fma_id","subj":"T348","obj":"http://purl.org/sig/ont/fma/fma62872"},{"subj":"T348","pred":"source","obj":"LitCovid-sample-PD-FMA"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T224","span":{"begin":0,"end":166},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T224","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#c3ec93","default":true},{"id":"LitCovid-sample-sentences","color":"#ec93dd"},{"id":"LitCovid-sample-PD-FMA","color":"#93ece0"},{"id":"LitCovid-sentences","color":"#ecc693"}]}]}}